Literature DB >> 23866425

Sarpogrelate- another new antiplatelet agent?

Quratulain Shaikh1, Ayeesha Kamran Kamal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23866425      PMCID： PMC4185068     

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN： 0030-9982            Impact factor:   0.781


× No keyword cloud information.
  3 in total

1.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Authors: 
Journal:  BMJ       Date:  2002-01-12

2.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

3.  Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS): A randomized, double-blind, aspirin-controlled trial.

Authors:  Yukito Shinohara; Katsuya Nishimaru; Tohru Sawada; Akiro Terashi; Shunnosuke Handa; Shunsaku Hirai; Kunihiko Hayashi; Hideo Tohgi; Yasuo Fukuuchi; Shinichiro Uchiyama; Takenori Yamaguchi; Shotai Kobayashi; Kazuoki Kondo; Eiichi Otomo; Fumio Gotoh
Journal:  Stroke       Date:  2008-04-03       Impact factor: 7.914
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.